Journal
THORAX
Volume 59, Issue 9, Pages 769-772Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/thx.2003.012930
Keywords
-
Categories
Ask authors/readers for more resources
Background: Iodo-resiniferatoxin (I-RTX) has recently been described as an ultra potent antagonist of the transient receptor potential vanilloid-1 (TRPV1). Methods: The ability of I-RTX to inhibit cough induced by inhalation of two putative TRPV1 stimulants ( capsaicin and citric acid) was tested in non-anaesthetised guinea pigs. Results: Pretreatment with I-RTX either intraperitoneally (0.03 - 0.3 mumol/kg) or by aerosol (0.1 - 3 muM) reduced the number of coughs produced by inhalation of citric acid (0.25 M) and capsaicin ( 30 muM) in a dose dependent manner. Capsazepine (CPZ) also reduced citric acid and capsaicin induced cough, but the activity of I-RTX was 10 - 100 times more potent than CPZ in all the experimental conditions tested. Conclusions: I-RTX is a novel and potent antitussive drug which inhibits cough mediated by agents possibly acting via TRPV1 activation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available